BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $204 from $255 and keeps a Buy rating on the shares. Sentiment ...

Truist lowered the firm’s price target on Icon (ICLR) to $208 from $262 and keeps a Buy rating on the shares as part of a broader research note ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. Lekha Gupta Clinical Research Firm ICON Faces ...